867064-24-2

Upstream product

• 867064-23-1 (9S)-9-(2-bromo-ethoxycarbonyloxy)-9-ethyl-1-pentyl-1H,12H-pyrano[3,4:6',7']indolizino[1',2' :6,5]pyrido[4,3;2-de]quinazoline-10,13(9H,15H)-dione 
• 172749-96-1 N-[(tert-butoxy)carbonyl]-L-cysteine methyl ester 
• 534605-78-2 C⁽⁹³⁰⁾H₀₇₇₆ 

Relevant academic research and scientific papers

AGENT FOR PREVENTING OR TREATING PANCREAS CANCER, OVARY CANCER OR LIVER CANCER CONTAINING NOVEL WATER-SOLUBLE PRODRUG

Preventive or therapeutic agents for pancreatic cancer, ovarian cancer, or liver cancer of the present invention comprise a water-soluble prodrug represented by formula 1 described below, or a pharmaceutically acceptable salt, or a hydrate or solvate of t

NOVEL ANTICANCER CONCOMITANT DRUG

A cancer therapeutic agent according to the present invention comprises a combination of compound A described below, or a pharmaceutically acceptable salt thereof, and compound B described below, or a pharmaceutically acceptable salt thereof: Compound A:

NOVEL WATER-SOLUBLE PRODRUG

An objective of the present invention is to provide water-soluble prodrugs that can be administered parenterally, and which show excellent water solubility and small interspecies or individual differences and are rapidly converted to the active form by ch